Zilxi Will Be a New Topical for Rosacea

June 2021

Zilxi (minocycline 1.5% foam) will be a new Rx med for rosacea.

Think of Zilxi as similar to Amzeeq (minocycline 4% foam) for acne...just at a lower strength for inflammatory rosacea.

But don't rush to stock up on Zilxi.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Encourage COVID-19 Vaccination for Adolescents
COVID-19 Help Increase COVID-19 Vaccine Acceptance
COVID-19 Know How Home Tests for COVID-19 Stack Up
Transdermal Patches Prevent Mix-Ups With Contraceptive Patches
Substance Use Disorder Expect More Buprenorphine Rxs for Opioid Use Disorder
Rosacea Zilxi Will Be a New Topical for Rosacea
Communication Be Ready to Help People Who Are Deaf or Hard of Hearing
Topicals Keep Patients Getting Topical Steroids Safe
Warnings Stay Alert for Heart Patients Getting Lamotrigine